GIM
XENT

Granahan Investment Management’s Intersect ENT, Inc XENT Stock Holding History

Granahan Investment Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-26,034
Closed -$445K – 208
2021
Q2 		$445K Buy
26,034
+12,207
+88% +$229K 0.01% 190
2021
Q1 		$289K Buy
+13,827
New +$319K 0.01% 188
2016
Q4 		– Sell
-284,541
Closed -$4.51M – 248
2016
Q3 		$4.51M Sell
284,541
-558,580
-66% -$8.41M 0.15% 156
2016
Q2 		$10.9M Buy
843,121
+293,800
+53% +$4.6M 0.4% 100
2016
Q1 		$10.4M Buy
549,321
+120,286
+28% +$2.18M 0.38% 92
2015
Q4 		$9.65M Buy
429,035
+62,600
+17% +$1.24M 0.33% 106
2015
Q3 		$8.57M Buy
+366,435
New +$10.1M 0.27% 128

Other funds holding XENT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Granahan Investment Management's XENT Position: Q3 2021 in Review

Granahan Investment Management sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 26,034 shares — an estimated $445K sold.

Granahan Investment Management first reported a position in XENT in Q3 2015 and held it in 7 quarters. The position peaked at $10.9M in Q2 2016. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.

  • Granahan Investment Management reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
  • Granahan Investment Management sold 26,034 Intersect ENT, Inc shares in Q3 2021, an estimated $445K.
  • Granahan Investment Management first reported a position in Intersect ENT, Inc in Q3 2015 and held it in 7 quarters.
  • Granahan Investment Management's Intersect ENT, Inc position peaked at $10.9M in Q2 2016.
  • 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.

Based on Granahan Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.